Welcome
Support Centre
11 February 2012 
Current Controlled Trials - Clinical Trials
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Introduction
English introduction Introduction en français Deutsche einleitung
Introducción española Introduzione in italiano
 
Find trials
active registers
mental health register
archived registers
all registers
tips on searching
 
 
Information
about mRCT
mRCT FAQs

DISCLAIMER
The site should not be used to diagnose or treat a health problem. Please consult your doctor.
Terms & conditions

DUPLICATION
Your search result may contain a number of different records for the same trial. This occurs when the same trial is listed in more than one register.

[ ...Back to search results ] [ Print-friendly version ]
Adjuvant Treatment of Gastric Cancer with Preoperative Intraperitoneal Mitomycin-C Bound to Carbon Particles
Source of recordUK Trials
ISRCTNISRCTN65411483
Date ISRCTN assigned19/08/2002
Local reference number(s)MMC-CH
Public titleAdjuvant Treatment of Gastric Cancer with Preoperative Intraperitoneal Mitomycin-C Bound to Carbon Particles
Scientific title
AcronymNot Applicable
Disease/condition/study domainStomach
Study hypothesisNot provided at time of registration
Design/methodologyRandomised controlled trial
Research ethics reviewNot provided at time of registration
Countries of trialUnited Kingdom
Participants - inclusion criteria1. Histologically documented adenocarcinoma of the stomach
2. All patients should have undergone surgery for resection of their primary malignancy
3. No evidence of distant or metastatic disease other than removable N1 or N2 lymph node metastases
4. No prior chemotherapy, radiotherapy or immunotherapy
5. Age <75 years and life expectancy greater than 3 months
6. Ambulatory performance status Karnofsky Grading 80%
7. Adequate bone marrow function
8. No evidence of organ failure
9. No evidence of intercurrent disease from previous malignancy
Participants - exclusion criteriaNot provided at time of registration
Patient information material
Anticipated end date31/12/1995
Status of trialCompleted
Target number of participantsNot provided at time of registration
Interventions1. Group A: Standard surgical resection plus 400 mg cimetidine daily for 12 months
2. Group B: Standard surgical resection with the intraperitoneal introduction of 50 mg Mitomycin-C bound to carbon particles just prior to surgical closure plus 400 mg cimetidine daily for 12 months
Primary outcome measure(s)Not provided at time of registration
Secondary outcome measure(s)Not provided at time of registration
Sources of fundingLeicester General Hospital
Sponsor nameLeicester General Hospital
Sponsor detailsGwendolen Road
Leicester
United Kingdom
LE5 4PW
Contact nameDr - -
Contact detailsUKCCCR Register Co-ordinator
MRC Clinical Trials Unit
222 Euston Road
London
United Kingdom
NW1 2DA
Contact telephone+44 (0) 20 7670 4723
Contact fax+44 (0) 20 7670 4818
Contact emailregister@ctu.mrc.ac.uk
More informationFor more up-to-date information please go to the ISRCTN link below.
Link to record in ISRCTN RegisterISRCTN65411483
Date last extracted from ISRCTN register17/04/2008
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 Current Controlled Trials Ltd. Part of Springer Science+Business Media. | terms & conditions | privacy statement


BioMed Central